DJO announced that it acquired orthopedic foot and ankle implant maker Trilliant Surgical for an undisclosed amount.
Dallas-based Colfax (NYSE:CFX) unit DJO’s acquisition is meant to support its focus on expansion into the high-growth U.S. foot and ankle market, which the company touts as a $1 billion market, according to a news release.
Trilliant’s product portfolio covers foot reconstruction/fixation procedures and the company additionally offers the novel Arsenal Foot Plating System, which features a design for greater flexibility and speed of implant placement. The companies believe the Arsenal system is poised to “be a plating leader.”
“As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgical’s positive patient impact globally,” Trilliant CEO Jon Olson said in the release. “DJO’s unparalleled commitment to new product development, their iconic brands and strong growth trajec…